Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 12,255,120 | 12,070,810 | 13,137,840 | 13,820,500 | 11,647,650 |
Cost of Goods | 3,672,229 | 3,733,722 | 4,358,652 | 4,180,544 | 3,563,427 |
Gross Profit | 8,582,893 | 8,337,090 | 8,779,189 | 9,639,959 | 8,084,226 |
Operating Expenses | 7,154,080 | 6,804,800 | 7,403,840 | 6,138,030 | 6,045,605 |
Operating Income | 1,429,047 | 1,533,008 | 1,375,999 | 3,502,472 | 2,039,047 |
Interest Expense | 358,608 | 274,682 | 674,357 | 346,111 | 220,261 |
Other Income | 454,451 | 163,941 | -982,002 | 218,767 | 54,521 |
Pre-tax Income | 1,524,891 | 1,422,267 | -280,359 | 3,375,128 | 1,873,307 |
Income Tax | 321,993 | 178,055 | 332,886 | 612,769 | 295,498 |
Net Income Continuous | 1,202,897 | 1,244,212 | -613,246 | 2,762,359 | 1,577,809 |
Minority Interests | 4,308 | 14,114 | -3,299 | 14,149 | 13,085 |
Net Income | $1,198,590 | $1,230,098 | $-609,947 | $2,748,210 | $1,564,724 |
EPS Basic Total Ops | 0.48 | 0.49 | -0.25 | 1.10 | 0.63 |
EPS Basic Continuous Ops | 0.48 | 0.50 | -0.25 | 1.10 | 0.63 |
EPS Diluted Total Ops | 0.48 | 0.49 | -0.25 | 1.10 | 0.63 |
EPS Diluted Continuous Ops | 0.48 | 0.50 | -0.25 | 1.10 | 0.63 |
EPS Diluted Before Non-Recurring Items | 0.93 | 0.96 | 0.89 | 1.39 | 0.95 |
EBITDA(a) | $1,429,047 | $1,533,008 | $1,375,998 | $3,502,472 | $2,039,047 |